Seattle Children’s Research Institute partners in immunotherapy startup
12.5.13 – NPR/KUOW Radio
Backed by $120 million in startup funding, Juno Therapeutics Inc. aims to develop immunotherapies that cure a wide range of cancers. Its founding partners are Seattle Children’s Research Institute, Fred Hutchinson Cancer Research Center and Memorial Sloan–Kettering Cancer Center.
Bellingham patient cured of leukemia, hoping to stay in remission
10.20.13 – Bellingham Herald
Last summer, the Ben Towne Center helped cure Lynsie Conradi of leukemia with a therapy that used her immune system to kill cancer cells. In August, she received a stem cell transplant that gives her the best chance to stay in remission.
Life sciences discovery fund grants Ben Towne Center $1 million
9.19.13 – Press Release
The award will fund vital studies of a cancer immunotherapy regimen that is in clinical trials in children and adults, in support of Dr. Michael Jensen’s vision to develop a leading immunotherapy program at Seattle Children’s.
First Washington patient to try leukemia therapy is cancer free
7.10.2013 – KOMO News
The first leukemia patient in the state to try a new cancer therapy from the Ben Towne Center, Lynsie Conradi, is disease-free. The treatment, called cellular immunotherapy, is designed for the toughest cases of leukemia.
Dr. Michael Jensen named to research “dream team”
4.07.2013 – Stand up to Cancer Press Release
The “dream team” includes Dr. Michael Jensen and researchers from several institutions who will together receive $14.5 million to pursue novel therapies for challenging childhood cancers. The team was named by Stand up to Cancer, the St. Baldrick’s Foundation and their scientific partner, the American Association for Cancer Research.